These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38701817)

  • 1. Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial.
    Mart MF; Boehm LM; Kiehl AL; Gong MN; Malhotra A; Owens RL; Khan BA; Pisani MA; Schmidt GA; Hite RD; Exline MC; Carson SS; Hough CL; Rock P; Douglas IS; Feinstein DJ; Hyzy RC; Schweickert WD; Bowton DL; Masica A; Orun OM; Raman R; Pun BT; Strength C; Rolfsen ML; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Ely EW; Jackson JC; Girard TD
    Lancet Respir Med; 2024 Apr; ():. PubMed ID: 38701817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
    Girard TD; Exline MC; Carson SS; Hough CL; Rock P; Gong MN; Douglas IS; Malhotra A; Owens RL; Feinstein DJ; Khan B; Pisani MA; Hyzy RC; Schmidt GA; Schweickert WD; Hite RD; Bowton DL; Masica AL; Thompson JL; Chandrasekhar R; Pun BT; Strength C; Boehm LM; Jackson JC; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Bernard GR; Dittus RS; Ely EW;
    N Engl J Med; 2018 Dec; 379(26):2506-2516. PubMed ID: 30346242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.
    Page VJ; Ely EW; Gates S; Zhao XB; Alce T; Shintani A; Jackson J; Perkins GD; McAuley DF
    Lancet Respir Med; 2013 Sep; 1(7):515-23. PubMed ID: 24461612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.
    Needham DM; Colantuoni E; Dinglas VD; Hough CL; Wozniak AW; Jackson JC; Morris PE; Mendez-Tellez PA; Ely EW; Hopkins RO
    Lancet Respir Med; 2016 Mar; 4(3):203-12. PubMed ID: 26832963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
    van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
    Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial.
    Smit L; Slooter AJC; Devlin JW; Trogrlic Z; Hunfeld NGM; Osse RJ; Ponssen HH; Brouwers AJBW; Schoonderbeek JF; Simons KS; van den Boogaard M; Lens JA; Boer DP; Gommers DAMPJ; Rietdijk WJR; van der Jagt M;
    Crit Care; 2023 Oct; 27(1):413. PubMed ID: 37904241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial.
    Stollings JL; Boncyk CS; Birdrow CI; Chen W; Raman R; Gupta DK; Roden DM; Rivera EL; Maiga AW; Rakhit S; Pandharipande PP; Ely EW; Girard TD; Patel MB
    JAMA Netw Open; 2024 Jan; 7(1):e2352034. PubMed ID: 38252439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.
    Girard TD; Pandharipande PP; Carson SS; Schmidt GA; Wright PE; Canonico AE; Pun BT; Thompson JL; Shintani AK; Meltzer HY; Bernard GR; Dittus RS; Ely EW;
    Crit Care Med; 2010 Feb; 38(2):428-37. PubMed ID: 20095068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands.
    Smit L; Trogrlić Z; Devlin JW; Osse RJ; Ponssen HH; Slooter AJC; Hunfeld NGM; Rietdijk WJR; Gommers D; van der Jagt M;
    BMJ Open; 2020 Sep; 10(9):e036735. PubMed ID: 32967873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Haloperidol Effects on Long-term Quality of Life in Critically Ill Patients at High Risk for Delirium: Results of the REDUCE Study.
    Rood PJT; Zegers M; Slooter AJC; Beishuizen A; Simons KS; van der Voort PHJ; van der Woude MCE; Spronk PE; van der Hoeven JG; Pickkers P; van den Boogaard M
    Anesthesiology; 2019 Aug; 131(2):328-335. PubMed ID: 31246603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial.
    Patel BK; Wolfe KS; Patel SB; Dugan KC; Esbrook CL; Pawlik AJ; Stulberg M; Kemple C; Teele M; Zeleny E; Hedeker D; Pohlman AS; Arora VM; Hall JB; Kress JP
    Lancet Respir Med; 2023 Jun; 11(6):563-572. PubMed ID: 36693400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for preventing intensive care unit delirium in adults.
    Herling SF; Greve IE; Vasilevskis EE; Egerod I; Bekker Mortensen C; Møller AM; Svenningsen H; Thomsen T
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009783. PubMed ID: 30484283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for the treatment of delirium in critically ill adults.
    Burry L; Hutton B; Williamson DR; Mehta S; Adhikari NK; Cheng W; Ely EW; Egerod I; Fergusson DA; Rose L
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011749. PubMed ID: 31479532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
    Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
    Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
    Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial.
    Schrijver EJ; de Vries OJ; Verburg A; de Graaf K; Bet PM; van de Ven PM; Kamper AM; Diepeveen SH; Anten S; Siegel A; Kuipéri E; Lagaay AM; van Marum RJ; van Strien AM; Boelaarts L; Pons D; Kramer MH; Nanayakkara PW
    BMC Geriatr; 2014 Aug; 14():96. PubMed ID: 25168927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
    Hui D; De La Rosa A; Wilson A; Nguyen T; Wu J; Delgado-Guay M; Azhar A; Arthur J; Epner D; Haider A; De La Cruz M; Heung Y; Tanco K; Dalal S; Reddy A; Williams J; Amin S; Armstrong TS; Breitbart W; Bruera E
    Lancet Oncol; 2020 Jul; 21(7):989-998. PubMed ID: 32479786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.